Owens & Minor (OMI) Gets a Sell Rating from Barclays


Barclays analyst Steven Valiquette maintained a Sell rating on Owens & Minor (NYSE: OMI) yesterday and set a price target of $12. The company’s shares closed yesterday at $15.41, close to its 52-week low of $14.26.

According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 9.5% and a 56.5% success rate. Valiquette covers the Services sector, focusing on stocks such as WellCare Health Plans, Molina Healthcare, and Centene Corp.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Owens & Minor with a $13 average price target.

See today’s analyst top recommended stocks >>

Owens & Minor’s market cap is currently $952.5M and has a P/E ratio of 15.11. The company has a Price to Book ratio of 0.93.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Owens & Minor, Inc. engages in provision of services to the manufacturers of healthcare products, supplies, and devices. It operates through the following segments: Domestic, International, and Proprietary. The Domestic segment consists of U.S. distribution, logistics, and value-added services business.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts